Menu UF Health Home Menu

NewsBriefs »

We invite you to explore some of our notable highlights led by interdisciplinary members of the UF Diabetes Institute. These important contributions strengthen our mission to improve the lives of individuals afflicted with this disease.

PicMonkey Collage2

Gator Engineer Brings $4.9 million to UF Diabetes Institute

Cherie Stabler, Ph.D., of the University of Florida College of Engineering, together with her team, recently won a $4.9 million grant to engineer a microchip that will serve to house islets that produce beta cells. Her team hopes to use the microchips to improve the current amount of islets available to transplant into patients with diabetes, as well as screen pharmaceuticals and create beta cells from stem cells.


On the Same Page: The UF Diabetes Institute

In the latest issue of On the Same Page, UF Health president David S. Guzick, M.D. Ph.D. details the events leading up to the formation of the new UF Diabetes Institute — a collaboration of dozens of researchers campuswide all focused on forging new advances in treatment for a disease that afflicts an estimated 29.1 million Americans and 1 in 10 Floridians.

PicMonkey Collage

The University of Florida Diabetes Institute

Together, UF is moving forward as a national leader in diabetes research, education, and patient care. Learn about the new developments that will strengthen ties between diabetes researchers across disciplines.

Bill Nelson

UF diabetes and aging study recognized by U.S. Senator

U.S. Senator Bill Nelson, D-FL took note of a recent UF study authored by affiliate diabetes investigator Todd Manini, Ph.D. which highlights a link between sitting and risk for diabetes. "We must continue funding groundbreaking research like that at the University of Florida and promoting the kinds of lifestyle changes that will reduce the risks of diseases like diabetes in old age," he said.


Celiac screening for kids with type 1 diabetes

Several studies to date have found that people with type 1 diabetes (T1D) tend to have celiac disease more often than individuals in the general population. Michael Haller, MD, a pediatric endocrinologist at UF Health, told Medscape Medical News in a recent interview that screening every type 1 diabetes patient for the disease presents a unique clinical challenge.

baby blanket resize

Bacterial interactions in the gut may influence type 1 diabetes

A new study co-authored by University of Florida diabetes researchers finds that bacteria in the guts of young children with type 1 diabetes are different from those of other kids. The research is helping clarify the importance of healthy gut bacteria development in early childhood and could help lead to novel prevention therapies for people at risk of developing the disease.


Screening for Gestational Diabetes

UF faculty in the Division of Obstetrics and Gynecology want to reduce the likelihood of further complications related to gestational diabetes, which occurs when pregnant women without a history of diabetes develop high blood glucose levels. A recent UF study with implications for all expectant mothers is the latest to shed light on this growing public health concern.

Cusi 150x150

Perspective: New Type 1 Diabetes Risk Factors

Kenneth Cusi, MD, adult medical director for the UF Diabetes Institute, recently gave his perspective on a small new study took the first step to demonstrate a link between non-alcoholic fatty liver disease (NAFLD) and an increased incidence of chronic kidney disease among type 1 diabetes patients. The editorial was published in the online magazine, EndocrineToday.


UF Researchers Named Among Top 10 Experts

UF Diabetes Institute co-directors Mark Atkinson, PhD and Desmond Schatz, MD, were recognized for their preeminent contributions in research and treatment of Type 1 diabetes mellitus. Learn more about this outstanding achievement.


Bone and Joint Health in Type 1 Diabetes

UF College of Dentistry faculty are moving advancements in diabetes care forward through efforts to prevent, reverse, and arrest oral complications associated with the disease. Researchers say they have made significant progress in understanding the important clinical connections between oral, bone, and joint health and type 1 diabetes.


Treatment could spur production of insulin in Type 1 diabetes

Combining two different medications could help patients with Type 1 diabetes at least partially regain the ability to produce their own insulin, according to UF Health pediatric endocrinologist Michael Haller, MD.